A new treatment has been proposed for immunotherapy-resistant brain metastases, with a biomarker identified that can predict ...

Researchers at the Spanish National Cancer Research Centre (CNIO) propose a new treatment for brain metastases that respond poorly, or not at all, to immunotherapy, and provide a biomarker to predict ...

Researchers have discovered a new chemical compound, MED6-189, that effectively combats drug-resistant malaria parasites.

Researchers at CNIO discovered that cancer manipulates brain cells called astrocytes, causing them to produce a protein that ...

The FDA bestows a Fast Track designation to Ionis' investigational candidate, zilganersen, for treating a rare neurological ...

In brain metastasis, cancer has been found to alter the course of certain astrocytes and causes them to produce a protein that works in the tumor's favor.

A drug called silibinin can block this protein and, when used with immunotherapy, may improve treatment for brain metastases.

Cells around a brain metastasis in an animal model: several brain cells (astrocytes, white) surround an immune system cell (lymphocyte, green). Some of them have started to activate the factor (red) ...

"The pharmacological and genetic modulation of astrocytic autophagy pathway can be considered for boosting the detoxifying ...